Dr. Reddy's Laboratories Email Format
Pharmaceutical ManufacturingTelangana, India10001+ Employees
Dr. Reddy's Laboratories is a global pharmaceutical manufacturer founded in 1984 and based in Hyderabad, Telangana, India. It develops and produces a diversified portfolio that includes APIs, generics, branded generics, biosimilars, and OTC products, with the aim of improving access to affordable and innovative medicines. The company serves major markets across the United States, India, Russia and the CIS, China, Brazil, and Europe, reflecting a broad international footprint grounded in scientific development. It emphasizes sustainability and governance, having released its first Sustainability Report in 2004 and pursuing ESG goals focused on environmental stewardship, patient access, diversity, and governance. In June 2026, Dr. Reddy's announced the US launch of a generic cancer drug, Bosutinib, indicated for chronic myeloid leukemia, illustrating ongoing expansion of its product portfolio into key markets.